28 posters,  4 sessions,  6 topics,  65 authors,  33 institutions

ePostersLive® by SciGen® Technologies S.A. All rights reserved.

Improving outcomes for Advanced Basal Cell Carcinoma: A Case Study

Primary tabs


No votes yet


531 reads


Improving Outcomes for Advanced Basal Cell Carcinoma: Case Study






Basal cell carcinoma (BCC) is the most common type of cancer, sub-divided into uncomplicated and advanced cases.


• Limited options when BCC progresses to an advanced state.


• Erivedge™ (vismodegib) was recently approved in Canada for the treatment of adult patients with histologically confirmed metastatic or locally advanced BCC where surgery or radiotherapy is not appropriate.


• We report early outcomes of 2 patients


Enter Poster ID (e.gGoNextPreviousCurrent